Brief: Oncopeptides Expects To See First Sales From Middle East And North Africa In H2
Aug 14 (Reuters) - Oncopeptides AB ONCO.ST :
* HOPE TO SEE FIRST SALES FROM MIDDLE EAST AND NORTH AFRICA
REGION
DURING SECOND HALF OF 2024 AND FROM NEWLY ADDED REGION IN EARLY
2025
Source text for Eikon: ID:nMFN1HDbKj
Further company coverage: ONCO.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Oncopeptides AB
See all newsSweden's Oncopeptides Q3 net sales rise on Pepaxti demand
Brief: Oncopeptides Q3 Operating Profit SEK -36.47 Million
Brief: Oncopeptides Completes Directed Share Issue Of SEK 100 Mln
Brief: Oncopeptides Confirms Blood-Brain-Barrier Penetration In Glioblastoma Study
Swedish biotech Oncopeptides' Q2 net sales rise on strong demand in Italy